Abstract
This report provides a comprehensive analysis of the global eye tracking in healthcare market, which is poised for significant growth driven by the rising prevalence of neurological and cognitive disorders. The study explores how eye tracking technology facilitates non-invasive diagnostics for conditions like dementia and ADHD, while highlighting the dominance of the remote tracking segment in telemedicine. Despite challenges regarding high equipment costs, the market is expanding through technological innovations and advanced infrastructure, particularly within North America.
Related Questions
US$ 802.87 million in 2024
21.4 % (2025-2033)
Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, ERGONEERS GmbH
Rising Prevalence of Neurological and Cognitive Disorders
Summary
Market Overview
The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is projected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4% during the forecast period of 2025-2033.
This market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person’s eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.
By monitoring eye movements, the technology can detect conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. Tracking patient focus allows healthcare professionals to gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.
Market Dynamics
Drivers
Rising Prevalence of Neurological and Cognitive Disorders: The increasing prevalence of neurological and cognitive conditions—such as Alzheimer’s disease, Parkinson’s disease, stroke, and autism spectrum disorders (ASD)—is a primary driver for the market. Eye tracking offers valuable insights into these disorders by analyzing eye movements to help identify early signs and aid in accurate diagnoses.
- Dementia Statistics: The World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, a figure expected to rise to 82 million by 2030.
- Parkinson’s Disease: This condition affects approximately 10 million people globally.
These growing numbers underscore the urgent need for better diagnostic tools. Eye tracking plays a critical role in assessing neurological function, detecting early changes in cognition, and providing a non-invasive method to monitor disease progression. As the global population ages, this technology is becoming an essential tool for clinicians to improve patient care and treatment outcomes.
Restraints
High Costs of Equipment and Implementation: The high costs associated with equipment and implementation act as a significant restraint, limiting widespread adoption in many healthcare settings. Eye tracking systems designed for medical diagnostics or neurological assessments often require high-end sensors, specialized software, and advanced hardware components.
- Investment Requirements: Clinical-grade systems capable of detecting subtle eye movements require significant investment in both equipment and supporting infrastructure.
- Precision Constraints: While eye tracking systems are available in a price range of $1.001 to $10,000, these specific systems may not meet the precision and reliability standards required for more advanced healthcare diagnostics, potentially limiting market growth.
Segment Analysis
The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.
Tracking Type
Remote Tracking: The remote tracking segment is expected to dominate the global eye tracking in healthcare market with the highest market share.
- Technological Integration: This segment leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.
- Clinical Applications: Remote tracking is crucial for telemedicine platforms, mobile health apps, and home-based monitoring systems. It allows healthcare providers to track patients from a distance, which is especially beneficial for the continuous monitoring of individuals with neurological conditions, cognitive disorders, or those undergoing rehabilitation therapies.
- Patient Benefits: It eliminates the need for regular visits to healthcare facilities, improving access to care and enhancing patient convenience, particularly for those with chronic conditions experiencing fluctuating symptoms.
- Clinical Advantages: By enabling analysis outside of medical environments, remote tracking offers greater flexibility, supports early detection of changes in cognitive or neurological health, and allows for real-time data collection to adjust treatment plans based on immediate insights.
Geographical Analysis
North America
North America is expected to hold a significant position in the global eye tracking in healthcare market, maintaining the highest market share.
- Diagnostic Drivers: The market is driven by the increasing application of eye tracking for diagnosing and monitoring neurological disorders like Parkinson’s disease, Alzheimer’s, and other cognitive impairments.
- Infrastructure & Research: The region benefits from an advanced healthcare system and technological infrastructure, housing leading research institutions and healthcare providers that integrate eye tracking into clinical practices (e.g., cognitive rehabilitation and assistive devices for motor disabilities).
- Cross-Industry Adoption: Increased adoption in consumer electronics, gaming, and the automotive industry further contributes to the broader use of eye tracking technology within healthcare settings.
Competitive Landscape
Key Vendors
The major global players in the eye tracking in healthcare market include:
- Tobii
- SR Research Ltd.
- iMotions
- Gazepoint
- EyeTech Digital Systems, Inc.
- Pupil Labs GmbH
- EyeTracking
- Smart Eye
- Lumen
- ERGONEERS GmbH
Key Developments
- Visage Imaging, Inc. (February 2024): Unveiled the Visage Ease VP for Apple Vision Pro. Designed for Apple’s spatial computing platform, it enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
- Tobii (January 2024): Launched the UX Explore cloud platform. This solution enhances mobile user experience (UX) research, allowing healthcare professionals and developers to efficiently evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices.
Why Purchase This Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and forming partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving healthcare regulations.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
Report Details: The report provides a complete view of the market landscape through 176 pages of expert insights, including 78 key tables and more than 71 visually impactful figures.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
Table of Contents
1 Market Introduction and Scope
1.1 Objectives of the Report
1.2 Report Coverage & Definitions
1.3 Report Scope
2 Executive Insights and Key Takeaways
2.1 Market Highlights and Strategic Takeaways
2.2 Key Trends and Future Projections
2.3 Snippet by Type
2.4 Snippet by Tracking Type
2.5 Snippet by Component
2.6 Snippet by Application
2.7 Snippet by End-User
2.8 Snippet by Region
3 Dynamics
3.1 Impacting Factors
3.1.1 Drivers
- 3.1.1.1 Rising Prevalence of Neurological and Cognitive Disorders
- 3.1.1.2 Advancements in Eye Tracking Technology
- 3.1.1.3 XX
3.1.2 Restraints
- 3.1.2.1 High Costs of Equipment and Implementation
- 3.1.2.2 Privacy and Data Security Concerns
- 3.1.2.3 XX
3.1.3 Opportunity
- 3.1.3.1 Integration with Virtual Reality (VR) and Augmented Reality (AR)
- 3.1.3.2 XX
3.1.4 Impact Analysis
4 Strategic Insights and Industry Outlook
4.1 Market Leaders and Pioneers
4.1.1 Emerging Pioneers and Prominent Players
4.1.2 Established leaders with the largest-selling Brand
4.1.3 Market leaders with established Product
4.2 CXO Perspectives
4.3 Latest Developments and Breakthroughs
4.4 Case Studies/Ongoing Research
4.5 Regulatory and Reimbursement Landscape
4.5.1 North America
4.5.2 Europe
4.5.3 Asia Pacific
4.5.4 Latin America
4.5.5 Middle East & Africa
4.6 Porter’s Five Forces Analysis
4.7 Supply Chain Analysis
4.8 Patent Analysis
4.9 SWOT Analysis
4.10 Unmet Needs and Gaps
4.11 Recommended Strategies for Market Entry and Expansion
4.12 Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13 Pricing Analysis and Price Dynamics
4.14 Key Opinion Leaders
5 Eye Tracking in Healthcare Market, By Type
5.1 Introduction
5.1.1 Analysis and Y-o-Y Growth Analysis (%), By Type
5.1.2 Market Attractiveness Index, By Type
5.2 Electrooculography (EOG)*
5.2.1 Introduction
5.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3 Tracking
5.3 Optical Tracking
5.4 Eye-Attached Tracking
6 Eye Tracking in Healthcare Market, By Tracking Type
6.1 Introduction
6.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
6.1.2 Market Attractiveness Index, By Tracking Type
6.2 Remote Tracking*
6.2.1 Introduction
6.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3 Mobile Tracking
7 Eye Tracking in Healthcare Market, By Component
7.1 Introduction
7.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2 Market Attractiveness Index, By Component
7.2 Hardware*
7.2.1 Introduction
7.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3 Software
8 Eye Tracking in Healthcare Market, By Application
8.1 Introduction
8.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2 Market Attractiveness Index, By Application
8.2 Medical Research & Diagnostics*
8.2.1 Introduction
8.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3 Assistive Technology
8.4 Cognitive & Neurological Studies
8.5 Ophthalmology & Vision Science
9 Eye Tracking in Healthcare Market, By End-User
9.1 Introduction
9.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2 Market Attractiveness Index, By End-User
9.2 Healthcare Providers*
9.2.1 Introduction
9.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3 Research Institutes
9.4 Assistive Device Manufacturers
10 Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities
10.1 Introduction
10.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2 Market Attractiveness Index, By Region
10.2 North America
10.2.1 Introduction
10.2.2 Key Region-Specific Dynamics
10.2.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.2.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.2.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.8.1 U.S
- 10.2.8.2 Canada
- 10.2.8.3 Mexico
10.3 Europe
10.3.1 Introduction
10.3.2 Key Region-Specific Dynamics
10.3.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.3.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.3.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.8.1 Germany
- 10.3.8.2 U.K
- 10.3.8.3 France
- 10.3.8.4 Spain
- 10.3.8.5 Italy
- 10.3.8.6 Rest of Europe
10.4 Latin America
10.4.1 Introduction
10.4.2 Key Region-Specific Dynamics
10.4.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.4.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.4.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.8.1 Brazil
- 10.4.8.2 Argentina
- 10.4.8.3 Rest of Latin America
10.5 Asia-Pacific
10.5.1 Introduction
10.5.2 Key Region-Specific Dynamics
10.5.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.5.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.5.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.8.1 China
- 10.5.8.2 India
- 10.5.8.3 Japan
- 10.5.8.4 South Korea
- 10.5.8.5 Rest of Asia-Pacific
10.6 Middle East and Africa
10.6.1 Introduction
10.6.2 Key Region-Specific Dynamics
10.6.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.6.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.6.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.7 Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11 Competitive Landscape and Market Positioning
11.1 Competitive Overview and Key Market Players
11.2 Market Share Analysis and Positioning Matrix
11.3 Strategic Partnerships, Mergers & Acquisitions
11.4 Key Developments in Product Portfolios and Innovations
11.5 Company Benchmarking
12 Company Profiles
12.1 Tobii*
12.1.1 Company Overview
12.1.2 Product Portfolio
- 12.1.2.1 Product Description
- 12.1.2.2 Product Key Performance Indicators (KPIs)
- 12.1.2.3 Historic and Forecasted Product Sales
- 12.1.2.4 Product Sales Volume
12.1.3 Financial Overview
- 12.1.3.1 Company Revenue
- 12.1.3.2 Geographical Revenue Shares
- 12.1.3.3 Revenue Forecasts
12.1.4 Key Developments
- 12.1.4.1 Mergers & Acquisitions
- 12.1.4.2 Key Product Development Activities
- 12.1.4.3 Regulatory Approvals, etc
12.1.5 SWOT Analysis
12.2 SR Research Ltd
12.3 iMotions
12.4 Gazepoint
12.5 EyeTech Digital Systems, Inc
12.6 Pupil Labs GmbH
12.7 EyeTracking
12.8 Smart Eye
12.9 Lumen
12.10 ERGONEERS GmbH
13 Assumptions and Research Methodology
13.1 Data Collection Methods
13.2 Data Triangulation
13.3 Forecasting Techniques
13.4 Data Verification and Validation
14 Appendix
14.1 About Us and Services
14.2 Contact Us